Key statistics dashboard for NeuroPace, Inc. (NPCE). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories.
Stock Data
| Price | $14.10 |
| Market Cap | $481M |
| Enterprise Value | $543.2M |
| Beta | 1.88 |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | -24.93 |
| Price / Book | 40.90 |
| P/S | 4.92 |
| EV/EBITDA | -44.21 |
| EV/Sales | 5.50 |
| EV/FCF | -46.79 |
| P/FCF | -41.85 |
| Earnings Yield | -3.93% |
| FCF Yield | -2.39% |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | 79.63% |
| EBIT Margin | -13.63% |
| EBITDA Margin | -12.43% |
| Operating Margin | -15.26% |
| Net Margin | -19.34% |
| Return on Equity | -119.68% |
| Return on Assets | -19.71% |
| Return on Invested Capital | -18.43% |
| Return on Capital Employed | -18.95% |
Financial Health
| Current Ratio | 4.94 |
| Quick Ratio | 3.91 |
| Cash Ratio | 0.72 |
| Debt / Equity | 5.88 |
| Debt / Assets | 72.10% |
| Net Debt / EBITDA | -4.67 |
| Interest Coverage | -2.39 |
| Piotroski F-Score | 5 |
| Altman Z-Score | -2.52 |
Per-Share Data
| Revenue per share | 2.90 |
| Book Value per share | 0.35 |
| Cash per share | 1.52 |
| FCF per share | -0.34 |
| Tangible Book Value per share | 0.35 |
| Dividend per share | 0.00 |
Related companies: ALDX · BWAY · CERS · CVRX · DCTH · GNLX · MASS
Explore sector: Healthcare · Medical - Devices
More sections of NPCE: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks